FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/078404 [Registered on: 20/12/2024] Trial Registered Prospectively
Last Modified On: 19/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Other 
Public Title of Study   Study to evaluate whether the drug levosimendan or milrinone has more impact on reducing left atrial pressure in patients undergoing off pump coronary artery bypass grafting  
Scientific Title of Study   A randomized comparative double blind study to evaluate the efficacy of levosimendan versus milrinone on reducing left atrial pressure in patients undergoing off pump coronary artery bypass grafting at SMS Medical College, Jaipur 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ashna Fathima 
Designation  Postgraduate Resident 
Affiliation  SMS Medical College, Jaipur 
Address  Department of Anaesthesiology, SMS Medical College, Jaipur

Jaipur
RAJASTHAN
302004
India 
Phone  7025088599  
Fax    
Email  ashna.mia29@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Anjum Saiyed 
Designation  Senior Professor 
Affiliation  SMS Medical College, Jaipur 
Address  Department of Anaesthesiology, SMS Medical College, Jaipur

Jaipur
RAJASTHAN
302004
India 
Phone  9214021930  
Fax    
Email  dranjumsaiyed@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Anjum Saiyed 
Designation  Senior Professor 
Affiliation  SMS Medical College 
Address  Department of Anaesthesiology, SMS Medical College, Jaipur

Jaipur
RAJASTHAN
302004
India 
Phone  9214021930  
Fax    
Email  dranjumsaiyed@gmail.com  
 
Source of Monetary or Material Support  
SMS MEDICAL COLLEGE, Jaipur, Rajasthan, India, Pincode 302004 
 
Primary Sponsor  
Name  Ashna Fathima 
Address  Postgraduate resident, Department of Anaesthesiology, SMS Medical College, Jaipur, Rajasthan, Pincode 302004 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ashna Fathima  SMS Medical College, Jaipur  CARDIOTHORACIC OPERATION THEATRE, SECOND FLOOR, BANGAD PARISHAR, SMS MEDICAL COLLEGE, JAIPUR
Jaipur
RAJASTHAN 
7025088599

ashna.mia29@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I251||Atherosclerotic heart disease of native coronary artery,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Levosimendan   Levosimendan 12 mcg/kg over 10 minutes diluted in 50 ml dextrose 5% in infusion pump followed by infusion of 0.1µg/kg/min intraoperatively started after induction upto completion of surgery 
Comparator Agent  Milrinone  Milrinone 50 mcg/kg in 50 ml dextrose 5% in infusion pump and will continue infusion of infusion 0.5µg/kg/min via infusion pump intraoperatively started after induction upto completion of surgery 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  ASA grade equal to or greater than 3
Patients with triple vessel coronary disease with ejection fraction greater than or equal to 40 percent 
 
ExclusionCriteria 
Details  Patients with mitral regurgitation
Patients who underwent conversion to on pump coronary artery bypass grafting
Patients with critical left main coronary artery disease
Patients undergoing redo surgery
Patients with atrial fibrillation
Patients with regional wall motion abnormalities
Patients with mitral annular disorders
Patients with preoperative use of Milrinone or Levosimendan or allergy to these drugs
Patients who are a part of any other research study
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Mean Mitral early diastolic inflow velocity (E),
Mean Early diastolic mitral annular velocity (e’)
 
T1 After sternotomy,
T2 During grafting of reverse saphenous venous graft in the proximal aorta,
T3 Grafting of left anterior descending artery,
T4 Grafting of obtuse marginal artery,
T5 Grafting of posterior descending artery,
T6 Before sternal closure
 
 
Secondary Outcome  
Outcome  TimePoints 
Heart Rate, Systolic blood pressure, Diastolic blood pressure, Mean blood pressure   baseline, postinduction 1 minute, after sternotomy, 30 minutes after induction, 6hrs after surgery, 12 hrs after surgery, 24 hrs after surgery 
Central venous pressure, Cardiac index, Stroke volume variation, Systemic vascular resistance index
 
baseline, postinduction 1 minute, after sternotomy, 30 minutes after induction 
complication, side effect  within 24 hrs of surgery 
 
Target Sample Size   Total Sample Size="76"
Sample Size from India="76" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   01/01/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study is to assess the comparative efficacy of levosimendan vs milrinone in reducing left atrial pressure in patients undergoing off pump coronary artery bypass grafting in SMS medical college Jaipur. The institutional ethics committee approval was obtained in october 2024.
 
Close